News

The Hippocratic Oath is a connection to ancient times and a call for humans to exhibit honorable behavior.

Diplopia is an unexpected and unwelcome complication that can occur, albeit rarely, after refractive surgery.

Based on the fact that extraordinary customer service can be a game changer to help position your practice for success in this unstable economy, this article builds from last month's piece on customer service.

Sun glare is a year-round problem, not just a summertime occurrence.

Dispensing high-end eyeglass frames is not as difficult as it may seem.

Advocates of glaucoma research and education are banding together to present Glaucoma 360?, three days of activities all geared toward increasing awareness of research, treating patients, and finding a cure for the nation's second-leading cause of preventable blindness.

An ophthalmic surgical simulator improved residents' operating room performance during phacoemulsification and improved patient outcomes.

With the Office of Inspector General's heightened awareness of coding and documentation errors, physicians should be aware of some specific areas to check and double-check in their daily routine of documentation.

As results from the FDA IDE clinical trial are awaited, analyses of data from patients receiving earlier versions of an investigational presbyopia-correcting intracorneal inlay show that its efficacy for improving near vision remains stable for at least 3 years.

The future of glaucoma medical therapy is contingent upon the correlation of ocular surface disease and glaucoma.

Bausch + Lomb and Technolas Perfect Vision hope the new femtosecond laser platform unveiled last month at the European Society of Cataract and Refractive Surgeons meeting will replace existing femtosecond laser systems.

Experience with a commercially available computer-based visual cortex training system indicates it is a useful option to consider for improving outcomes of patients with complaints about visual acuity and quality after premium IOL surgery.

European surgeons have access to a wide and expanding range of premium IOLs for implantation after cataract surgery/refractive lens exchange as well as several phakic IOLs.

Findings from a retrospective study assessing vision and well-being among patients with presbyopic hyperopia who underwent bilateral wavefront-guided LASIK or refractive lens exchange with bilateral multifocal IOL implantation show similarly high satisfaction for both groups.

Each decision made in managing your staff presents as a new journey.

ARVO's Web seminars are an opportunity to acquire the best practices and practical tools from experienced professionals without leaving one's office or home.

Grafting a thicker amniotic membrane onto the ocular surface may be a promising solution for patients who experience graft failure or require ocular surface reconstruction after penetrating keratoplasty.

In a retrospective chart review that compared three of the most current phacoemulsification technologies for their performance and outcomes during cataract surgery and day 1 after surgery, the Infiniti OZIL-IP outperformed the WhiteStar Signature Ellipsis-FX and the Stellaris System with respect to less phaco needle time, increased followability and stability, less chatter, and less change in corneal pachymetry after surgery that resulted in better day 1 visual outcomes.

Implantation of a toric IOL in eyes with low pre-existing cylinder has benefit for significantly reducing postoperative astigmatism, but surgeons should be mindful of the importance of minimizing surgically induced astigmatism when using a low-cylinder power toric IOL.

The femtosecond laser brings a new level of precision to multiple steps of cataract surgery and improves the accuracy, predictability, and safety of patient outcomes.

Myopic LASIK using a 400-Hz excimer laser is safe, effective, and predictable whether done with a wavefront-guided or wavefront-optimized technique.

A new Web site helps subscribers prepare for their OKAP exams, written boards and recertification for boards.

Results of a prospective, randomized, patient-masked clinical trial evaluating three presbyopia-correcting IOLs show predictable refractive outcomes were achieved with all three technologies, but indicate there are some differences between the IOLs in visual performance, said Robert E.T. Ang, MD, Asian Eye Institute, Makati City, Philippines.

The European Commission (EC) has granted orphan drug status for an immunosuppressant drug (Sirolimus, Santen Inc.) for the treatment of chronic non?infectious uveitis. The designation follows a positive opinion from the Committee for Orphan Medicinal Products within the European Medicines Agency in June.

The Centers for Medicare and Medicaid Services (CMS) has granted transitional pass-through payment status and established a billing code for a telescope implant (Implantable Miniature Telescope [IMT] by Dr. Isaac Lipshitz, VisionCare Ophthalmic Technologies, Inc.) under the Hospital Outpatient Prospective Payment System. The new pass-through code, C1840, is effective October 1. It will enable outpatient facilities to obtain reimbursement for the telescope implant for covered procedures.

The Glaucoma Research Foundation (GRF) will present Glaucoma 360, a three-day series of events offering a ?full-compass view? of the cure, catalysts, and care of glaucoma, Feb. 2 to 4, 2012, at the Palace Hotel in San Francisco.

Accutome has launched a new e-commerce Web site, www.accutome.com, that features more than 2,500 ophthalmic products.

Upon receiving CE mark approval to market in Europe, OptiMedica Corp. expects to begin shipping its laser system for cataract surgery (Catalys Precision) in the fourth quarter of this year.

The Massachusetts Eye and Ear Infirmary (MEEI) has received an $11 million grant from the National Institute of Allergy and Infectious Disease, the largest National Institutes of Health grant in the hospital?s 187-year history, to coordinate the Harvard-wide Project on Antibiotic Resistance.

Ophthalmology Times Editorial Advisory Board member Julia A. Haller, MD, was formally named the first holder of the William Tasman, MD, Endowed Chair in Ophthalmology at the Wills Eye Institute on Sept. 8.